Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed-Reference-Cited by-同舟云学术

Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed

Published:2021-11-01 Issue:21 Volume:60 Page:3441-3445
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Nonomura Ayami¹,Tamori Akihiro¹,Hai Hoang¹,Kozuka Ritsuzo¹,Fujii Hideki¹,Uchida-Kobayashi Sawako¹,Enomoto Masaru¹,Kawada Norifumi¹

Affiliation:

1. Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/21/60_7028-21/_pdf

Reference19 articles.

1. 1. Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet 394: 1451-1466, 2019.

2. 2. Ikeda H, Watanabe T, Atsukawa M, et al. Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2 infected patients in a real-world setting in Japan. J Viral Hepat 26: 1266-1275, 2019.

3. 3. Ogawa E, Furusyo N, Nakamuta M, et al. Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study. Hepatol Res 49: 617-626, 2019.

4. 4. Uemura H, Uchida Y, Kouyama JI, et al. NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir. J Gastroenterol 54: 459-470, 2019.

5. 5. Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology. Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update. Hepatol Res 50: 791-816, 2020.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus: History and Current Knowledge;Gastroenterology Insights;2024-08-08

2. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral;Global Health & Medicine;2021-10-31

3. Multiple drugs;Reactions Weekly;2021-07